MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 215 filers reported holding MIRATI THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.31 and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $38 | +123.5% | 883 | +77.7% | 0.00% | – |
Q2 2023 | $17 | -83.3% | 497 | -78.4% | 0.00% | -100.0% |
Q4 2022 | $102 | -100.0% | 2,300 | -78.0% | 0.00% | -75.0% |
Q2 2022 | $701,000 | +270.9% | 10,448 | +349.6% | 0.00% | +300.0% |
Q1 2022 | $189,000 | +1011.8% | 2,324 | +324.9% | 0.00% | – |
Q1 2018 | $17,000 | – | 547 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aviva Holdings Ltd. | 2,881,702 | $14,985,000 | 6.99% |
Avoro Capital Advisors LLC | 2,383,201 | $12,393,000 | 1.58% |
Broadfin Capital, LLC | 2,090,801 | $10,872,000 | 1.32% |
Boxer Capital, LLC | 1,037,994 | $5,398,000 | 1.18% |
Ghost Tree Capital, LLC | 172,184 | $895,000 | 0.17% |
Baker Brothers Advisors | 2,269,198 | $11,800,000 | 0.10% |
Hillhouse Capital Management | 725,000 | $3,770,000 | 0.07% |
SABBY MANAGEMENT, LLC | 249,735 | $1,299,000 | 0.07% |
Rhenman & Partners Asset Management AB | 50,000 | $260,000 | 0.04% |
Trexquant Investment LP | 42,879 | $223,000 | 0.03% |